Ignite Creation Date:
2024-05-05 @ 12:07 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00247364
Status:
COMPLETED
Last Update Posted:
2005-11-01
First Post:
2005-10-28
Brief Title:
A Double Blind Crossover Trial of Levetiracetam Keppra and Placebo in the Treatment of Restless Legs Syndrome RLS
Sponsor:
Sleep Health Centers
Organization:
Sleep Health Centers
Study Overview
Official Title:
A Double Blind Crossover Trial of Levetiracetam Keppra and Placebo in the Treatment of Restless Legs Syndrome RLS
Status:
COMPLETED
Status Verified Date:
2005-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To define the effective dose and tolerability of levetiracetam in individuals with Restless Legs Syndrome RLS It is hypothesized that levetiracetam will be well tolerated safe and effective in treating the symptoms of RLS
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None